最新消息

News & Message

:::
2025/7/19

Prediction of methicillin-resistant Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae from Raman spectra by Artificial Intelligent Raman Detection and Identification System (AIRDIS) with machine learning

Abstract
Objectives

Methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Klebsiella pneumoniae (CRKP) are two of the most important antibiotic-resistant bacteria. Early use of the correct treatment strategy can not only reduce patient mortality but also prevent the development of resistance. Although some rapid but costly techniques are available, routine workflows in clinical microbiology laboratories can sometimes take several days to deliver bacterial identification and resistance profiles. In this study, we developed a bacterial identification and resistance prediction system that combines Raman spectroscopy and machine learning to predict the MRSA and CRKP.


Methods

A total of 988 S. aureus isolates (including 513 MRSA) and 1053 K. pneumoniae isolates (including 517 CRKP) were collected. Of these, 266 S. aureus isolates and 285 K. pneumoniae isolates were used for training, while the remainder were used for validation.


Results

The system demonstrated high predictive performance, with accuracy and area under receiver operating characteristic (AUROC) values of 88% and 0.92 for MRSA prediction and 87% and 0.96 for CRKP prediction, respectively.


Conclusions

As a result, we confirmed the ability of machine learning to interpret Raman spectra for predicting resistant bacteria in clinical microbiology laboratories. This is the first and novel system validated with a large number of clinical isolates and may be incorporated into existing workflows.
Keywords: Artificial Intelligence; Carbapenem-resistant Klebsiella pneumoniae; Machine learning; Methicillin-resistant Staphylococcus aureus; Prediction; Raman spectra.

這項研究介紹了名為 AIRDIS 的人工智慧拉曼檢測與鑑定系統,旨在針對臨床上極具威脅的 MRSA(抗藥性金球菌)與 CRKP(抗藥性克雷伯氏肺炎菌)提供快速預測。傳統微生物鑑定與抗藥性測試往往需耗時數日,而該系統透過 拉曼光譜 技術結合 深度學習 模型,能從細菌的生化特徵中自動提取細微差異。研究團隊收集了超過兩千株臨床分離株進行訓練與驗證,結果顯示該模型在預測抗藥性方面達到 87% 至 88% 的準確率。此技術具備非破壞性且無須標記的優點,能大幅縮短診斷流程並減少病患死亡率。AIRDIS 已獲得美國 FDA 的分類建議,展現出整合進現有醫療工作流並對抗全球 抗藥性(AMR) 危機的巨大潛力。

全文連結: https://pubmed.ncbi.nlm.nih.gov/40750044/

相關文章

▲至頂